Variable association of complement activation by rituximab and paclitaxel in cancer patients in vivo and in their screening serum in vitro with clinical manifestations of hypersensitivity: a pilot study-Reference-Cited by-同舟云学术

Variable association of complement activation by rituximab and paclitaxel in cancer patients in vivo and in their screening serum in vitro with clinical manifestations of hypersensitivity: a pilot study

Published:2015-01-01 Issue:4 Volume:7 Page:
ISSN:1662-596X
Container-title:European Journal of Nanomedicine
language:
Short-container-title:

Author:

Kozma Gergely Tibor,Mészáros Tamás,Weiszhár Zsóka,Schneider Tamás,Rosta András,Urbanics Rudolf,Rosivall László,Szebeni János

Abstract

AbstractTo explore the role of complement (C) activation in the hypersensitivity reactions (HSRs) to some anticancer drugs, as well as the use of the C activation biomarkers (C

Publisher

Walter de Gruyter GmbH

Subject

Physical and Theoretical Chemistry,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.degruyter.com/document/doi/10.1515/ejnm-2015-0026/pdf

Reference94 articles.

1. Hypersensitivity reactions from antineoplastic agents;Weiss;Cancer Rev,1987

2. activation - related pseudoallergy : a stress reaction in blood triggered by nanomedicines and;Szebeni;Complement biologicals Mol Immunol,2014

3. Mechanisms of killing by anti - CD monoclonal antibodies;Glennie;Mol Immunol,2007

4. Hemocompatibility testing for nanomedicines and predictive assays for complement mediated infusion reactions;Szebeni;biologicals Eur,2012

5. Activation of complement by therapeutic liposomes and other lipid excipient - based therapeutic products : prediction and prevention;Szebeni;Adv Drug Deliver Rev,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and Efficacy of a Nanomedical Radiopharmaceutical for Cancer Treatment;ACS Omega;2023-01-04

2. Hypersensitivity reactions to biologics in children;Expert Opinion on Biological Therapy;2023-01-02

3. Subvisible Particles in IVIg Formulations Activate Complement in Human Serum;Journal of Pharmaceutical Sciences;2020-01

4. Nanomaterials at the Biological Interphase: Protein Corona Formation and Infusion Reactions;Nanomaterial - Based Biomedical Applications in Molecular Imaging, Diagnostics and Therapy;2020

Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice

;International Journal of Nanomedicine;2019-02